Telferscot Resources Inc Stock Canadian Securities Exchange
Equities
TFS
CA87957T1066
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
Sales 2021 | - | Sales 2022 | 0.29 0 | Capitalization | 11.48M 0 |
---|---|---|---|---|---|
Net income 2021 | -4M - | Net income 2022 | -3M - | EV / Sales 2021 | - |
Net Debt 2021 | 75.05K 0 | Net Debt 2022 | 1.15M 0 | EV / Sales 2022 | 43,043,762 x |
P/E ratio 2021 |
-7.9
x | P/E ratio 2022 |
-3.02
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 86.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-04-19 | |
President | 56 | 16-04-19 | |
Chief Tech/Sci/R&D Officer | - | 20-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 56 | 16-04-19 | |
Barry Polisuk
BRD | Director/Board Member | 61 | 18-04-10 |
Vitor Fonseca
BRD | Director/Board Member | 71 | 18-04-10 |
1st Jan change | Capi. | |
---|---|---|
+42.38% | 6.26B | |
-15.86% | 4.49B | |
+6.36% | 3.29B | |
-11.28% | 3.12B | |
-3.23% | 2.5B | |
+45.24% | 1.94B | |
-7.89% | 1.68B | |
-0.98% | 1.63B | |
-11.32% | 1.56B |
- Stock Market
- Equities
- PILL Stock
- TFS Stock